SeaStar Medical (ICU) regains Nasdaq $1.00 minimum bid price compliance

Rhea-AI Filing Summary

SeaStar Medical Holding Corporation reported that it has regained compliance with Nasdaq’s minimum bid price requirement. On January 20, 2026, the company received confirmation from the Nasdaq Office of General Counsel that it once again meets the $1.00 minimum bid price standard set by Nasdaq Listing Rule 5550(a)(2). This means SeaStar Medical’s common stock and warrants continue to qualify for listing on The Nasdaq Stock Market, removing the immediate risk that its shares could be delisted solely for not meeting the bid price rule.

Positive

• Regained Nasdaq minimum bid price compliance, removing an immediate risk of delisting related to Nasdaq Listing Rule 5550(a)(2).

Negative

• None.

Insights

Equity & Listing Standards Analyst

SeaStar Medical removes an immediate Nasdaq delisting risk by regaining the $1.00 bid price compliance.

SeaStar Medical Holding Corporation received confirmation on January 20, 2026 that it is back in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum $1.00 bid price. This indicates that, over the relevant measurement period, the company’s share price met or exceeded Nasdaq’s continued listing standard for bid price.

Maintaining compliance with this rule helps preserve the company’s listing of its common stock and warrants on The Nasdaq Stock Market. Continued Nasdaq listing typically supports trading liquidity and market visibility, compared with moving to a less prominent marketplace. Actual future impact will depend on how the share price behaves relative to Nasdaq’s standards over time.

Investors can now interpret the prior bid-price deficiency as resolved as of January 20, 2026, based on Nasdaq’s letter. Subsequent company disclosures will show whether SeaStar Medical maintains ongoing compliance with Nasdaq’s quantitative listing criteria and whether any new deficiencies arise.

false 0001831868 0001831868 2026-01-20 2026-01-20 0001831868 icu:CommonStockCustomMember 2026-01-20 2026-01-20 0001831868 icu:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockFor1150PerShareCustomMember 2026-01-20 2026-01-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 20, 2026

SeaStar Medical Holding Corporation

(Exact name of Registrant as Specified in Its Charter)

Delaware	001-39927	85-3681132
(State or Other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)
3513 Brighton Blvd,
Suite 410
Denver, Colorado		80216
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: 844 427-8100

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

		Trading
Title of each class		Symbol(s)		Name of each exchange on which registered
Common Stock par value $0.0001 per share		ICU		The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share		ICUCW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01.         Other Events

Regaining Compliance with the $1.00 Bid Price Rule

On January 20, 2026, the Company received a letter from the Nasdaq Office of General Counsel confirming that the Company has regained compliance with the minimum bid price requirement of the Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule").

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			SeaStar Medical Holding Corporation
		By:	/s/ Eric Schlorff
Date:	January 20, 2026	Name:	Eric Schlorff
		Title:	Chief Executive Officer

FAQ

What did SeaStar Medical Holding Corporation (ICU) disclose in this 8-K?

SeaStar Medical Holding Corporation disclosed that on January 20, 2026, it received a letter from the Nasdaq Office of General Counsel confirming it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

What is the Nasdaq minimum bid price rule mentioned for ICU?

The filing states that SeaStar Medical has regained compliance with the Nasdaq Listing Rule 5550(a)(2), referred to as the Minimum Bid Price Rule, which requires a minimum $1.00 bid price for continued listing on The Nasdaq Stock Market.

When did Nasdaq confirm SeaStar Medical’s compliance with the $1.00 bid price rule?

Nasdaq’s Office of General Counsel sent a letter dated January 20, 2026, confirming that SeaStar Medical had regained compliance with the $1.00 minimum bid price requirement.

Which SeaStar Medical securities are listed on Nasdaq?

The filing lists SeaStar Medical’s Common Stock, par value $0.0001 per share, trading under the symbol ICU, and its warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share, trading under the symbol ICUCW on The Nasdaq Stock Market LLC.

Why is regaining compliance with Nasdaq’s bid price rule important for ICU shareholders?

Regaining compliance with the $1.00 minimum bid price rule helps SeaStar Medical maintain its listing on The Nasdaq Stock Market, which can support trading liquidity and accessibility for shareholders compared with being moved off a major exchange.

Who signed the 8-K for SeaStar Medical Holding Corporation?

The report was signed on behalf of SeaStar Medical Holding Corporation by Eric Schlorff, who is identified as the company’s Chief Executive Officer.